샘플 요청 목록

 카트 문의
시장보고서
상품코드
1759009

세계의 경막 이식 시장

Dural Graft
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 499 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

경막 이식 세계 시장은 2030년까지 11억 달러에 이를 전망

2024년에 8억 1,350만 달러로 추정되는 경막 이식 세계 시장은 2030년에는 11억 달러에 이르고, 분석 기간인 2024-2030년 CAGR은 4.5%를 보일 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 이종 이식은 CAGR 4.4%를 나타내고, 분석 기간 종료시에는 3억 4,190만 달러에 이를 것으로 예측됩니다. 동종 이식 부문의 성장률은 분석 기간중 CAGR 5.1%로 추정됩니다.

미국 시장은 2억 2,160만 달러, 중국은 CAGR 8.1%로 성장 예측

미국의 경막 이식 시장은 2024년에 2억 2,160만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR 8.1%로 2030년까지 2억 1,810만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.9%와 3.5%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.6%를 보일 전망입니다.

세계의 경막 이식 시장 - 주요 동향과 촉진요인 정리

경막 이식 도입을 위한 의료계의 원동력은?

경막 이식은 신경외과 및 척추 수술, 특히 경막 파열, 두개골 감압술, 척추 경막외 성형술과 같은 경우 신경외과 및 척추 수술의 핵심이 되고 있습니다. 이러한 이식편은 뇌와 척수를 감싸고 있는 보호막인 경막의 중요한 패치 또는 대체물 역할을 합니다. 외상성 뇌손상, 척수 손상 및 신경외과 수술의 발생률이 증가함에 따라 신뢰할 수 있는 경막 복구 재료에 대한 수요가 증가하고 있습니다. 뇌척수액(CSF) 누출과 같은 수술 후 합병증에 대한 인식이 높아지면서 효과적인 경막 폐쇄의 중요성이 그 어느 때보다 강조되고 있습니다. 외과의사들은 현재 기능적 장벽 역할을 할 뿐만 아니라 원래의 조직과 잘 융합되어 치유를 촉진하고 감염과 유착의 위험을 감소시키는 이식편을 우선시하고 있습니다. 수술 결과를 개선하고 합병증을 최소화하기 위한 의료 시스템의 변화는 전 세계적으로 첨단 경막 이식재 채택을 가속화하는 데 중요한 역할을 하고 있습니다.

재료의 혁신은 이식편의 기능성을 어떻게 변화시키고 있는가?

경막이식재 시장에서 가장 중요한 발전 중 하나는 생체재료의 진화입니다. 원래 환자 자신의 몸에서 채취한 자가 이식편이 표준으로 여겨졌으나, 공여 부위의 이환율과 수술 시간 연장 등의 한계로 인해 합성 및 이종 이식편에 대한 대안이 개발되고 있습니다. 오늘날 경막 이식재에는 콜라겐 기반 이종 이식재(일반적으로 소 또는 돼지 유래), 폴리우레탄 및 발포 폴리테트라플루오로에틸렌(ePTFE)과 같은 합성 고분자, 하이브리드 생체공학 재료 등이 있습니다. 이러한 재료는 우수한 생체 적합성, 인장 강도, 수밀성 밀봉 기능을 제공하며, 종종 항염증 코팅 및 제어된 분해 타임라인과 같은 부가적인 이점을 제공합니다. 또한, 일부 제품은 자생 세포의 증식 및 조직 재생을 촉진하는 비계 구조를 가지고 있습니다. 또한, 무봉합 이식편과 실란트 호환 이식편은 시술의 용이성과 속도를 크게 향상시켰습니다. 이러한 기술적 강화는 수술의 효율성을 높일 뿐만 아니라, 임상적 의사결정에 있어 중요한 요소인 수액 누출 및 감염의 위험을 감소시킵니다.

지역 의료 시스템이 이식편 사용을 가속화하는 이유는 무엇일까?

의료 인프라, 규제 당국의 승인 절차, 수술 건수 등에 따라 경막외이식재 사용은 지역별로 다르게 나타나고 있습니다. 북미와 유럽은 강력한 신경외과 네트워크, 높은 수술 건수, 유리한 상환제도에 힘입어 경막외이식재 사용률에서 선두를 달리고 있습니다. 이들 지역에서는 고급 이식재에 대한 접근성이 높고, 임상의들이 근거에 기반한 제품에 대한 선호도가 높습니다. 한편, 아시아태평양에서는 의료 접근성 확대, 수술의 질에 대한 인식 증가, 외상 관련 신경외과 수술 사례 증가로 인해 수요가 급증하고 있습니다. 또한, 인도와 중국 같은 국가에서는 3차 병원과 전문병원의 수술 능력이 빠르게 향상되고 있어 첨단 경막 복원 제품의 채택이 증가하고 있습니다. 라틴아메리카와 중동 및 아프리카의 일부 지역에서는 시장 성장이 비교적 초기 단계에 있지만, 세계 의료 기술 기업들이 신흥 시장에 맞게 조정된 비용 효율적인 이식 솔루션을 도입하면서 시장 성장에 탄력을 받고 있습니다. 이러한 시장 다변화는 전체 시장의 잠재력을 넓히고 경막 이식 기술이 더 널리 받아들여질 수 있도록 돕고 있습니다.

경막이식재 시장의 성장세를 견인하는 요인은 무엇인가?

경막 이식재 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 그 중 가장 중요한 것은 효과적인 경막 복구 솔루션이 필요한 신경외과 및 척추 수술의 수가 전 세계적으로 증가하고 있다는 점입니다. 생체 적합성 향상, 염증 반응 감소, 조직 재생 지원 등 이식재 설계의 혁신은 외과 의사의 신뢰와 임상 결과를 향상시키고 있습니다. 최소침습 수술로의 전환은 더 작은 수술 통로에서 빠르고 안정적으로 배치할 수 있는 첨단 이식편을 지지하고 있습니다. 또한, 수액 관련 합병증에 대한 인식이 높아지면서 수술 후 이식의 사용률이 감소하고, 우수한 밀봉 기능을 갖춘 이식편이 출시되면서 이식편 채택이 더욱 가속화되고 있습니다. 신제품에 대한 규제 당국의 승인과 이식편 사용에 대한 임상적 적응증 확대는 선진국과 신흥국의 의료 시스템에서 이러한 장치를 보다 쉽게 사용할 수 있도록 돕고 있습니다. 환자 회복 지표, 재입원율, 장기적 결과에 대한 관심이 높아짐에 따라 의료 기관은 신뢰할 수 있고 검증된 이식 기술에 투자하고 있습니다. 이러한 요인들이 복합적으로 작용하여 세계 경막이식재 시장은 지속적이고 가속화된 성장 단계에 접어들었습니다.

부문

제품(이종 경막 이식재, 동종 경막 이식재, 합성 경막 이식재, 자가 경막 이식재, 기타 제품); 재료(소 심막 재료, 사체 경막 재료, 자가 심막 재료, 합성 소 콜라겐 매트릭스 재료, 인대 누채 재료, 기타 재료); 애플리케이션(외상성 뇌 및 척추 손상 애플리케이션, 뇌혈관 사고 애플리케이션, 뇌척수액 축적 애플리케이션, 뇌 및 척추 종양 애플리케이션, 뇌전증 애플리케이션, 기타 애플리케이션); 최종 용도(병원 최종 용도, 외래 수술 센터 최종 용도, 외상 센터 최종 용도, 클리닉 최종 용도).

조사 대상 기업 예(총 43개사)

  • Acera Surgical
  • Aesculap, Inc.(B. Braun)
  • Baxter International Inc.
  • Beijing TianXinFu Medical Appliance
  • B. Braun Melsungen AG
  • Collagen Matrix, Inc.
  • Cook Medical
  • Cousin Biotech
  • Guanhao Biotech
  • Gunze Limited
  • Integra LifeSciences Corporation
  • Johnson & Johnson(DePuy Synthes)
  • LeMaitre Vascular
  • Medprine
  • Medtronic plc
  • Natus Medical Incorporated
  • Nurami Medical
  • Stryker Corporation
  • Tissuemed Ltd
  • WL Gore & Associates

AI 통합

우리는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.15

Global Dural Graft Market to Reach US$1.1 Billion by 2030

The global market for Dural Graft estimated at US$813.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Xenogeneic Dural Graft, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$341.9 Million by the end of the analysis period. Growth in the Allogenic Dural Graft segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$221.6 Million While China is Forecast to Grow at 8.1% CAGR

The Dural Graft market in the U.S. is estimated at US$221.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$218.1 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Dural Graft Market - Key Trends & Drivers Summarized

What’s Driving the Medical Community Toward Dural Graft Adoption?

Dural grafts have become a cornerstone in neurosurgical and spinal procedures, especially in cases involving dural tears, cranial decompression, and spinal duraplasty. These grafts serve as critical patches or substitutes for the dura mater-the protective membrane surrounding the brain and spinal cord-especially when the native dura is damaged or removed. The rising incidence of traumatic brain injuries, spinal disorders, and neurosurgical interventions has created a robust demand for reliable dural repair materials. As awareness of postoperative complications such as cerebrospinal fluid (CSF) leaks grows, the importance of effective dural closure has never been more emphasized. Surgeons now prioritize grafts that not only serve a functional barrier but also integrate well with native tissue, promote healing, and reduce the risk of infection or adhesion. The healthcare system’s shift toward improving surgical outcomes and minimizing complications is playing a critical role in accelerating the adoption of advanced dural graft materials across the globe.

How Are Material Innovations Transforming Graft Functionality?

One of the most significant developments in the dural graft market lies in the evolution of biomaterials. Originally, autologous grafts taken from the patient's own body were considered the gold standard, but their limitations-such as donor site morbidity and extended surgery time-spurred the development of synthetic and xenogeneic alternatives. Today’s dural grafts include collagen-based xenografts (typically derived from bovine or porcine sources), synthetic polymers like polyurethane or expanded polytetrafluoroethylene (ePTFE), and hybrid bioengineered materials. These offer excellent biocompatibility, tensile strength, and watertight sealing capabilities, often with added benefits such as anti-inflammatory coatings or controlled degradation timelines. Some are also engineered with scaffold structures that encourage native cell proliferation and tissue regeneration. Furthermore, sutureless grafts and sealant-compatible grafts have significantly improved procedural ease and speed. These technological enhancements not only make surgeries more efficient but also reduce the risk of CSF leaks and infection, key factors in clinical decision-making.

Why Are Regional Healthcare Systems Accelerating Graft Usage?

Different geographic regions exhibit varied dynamics in dural graft adoption, driven by healthcare infrastructure, regulatory approval processes, and surgical volumes. North America and Europe lead in usage, supported by strong neurosurgical networks, high procedural volumes, and favorable reimbursement frameworks. In these regions, there is greater availability of premium graft materials and stronger clinician preference for evidence-backed products. Asia-Pacific, on the other hand, is experiencing a surge in demand driven by expanding healthcare access, growing awareness about surgical quality, and increasing incidences of trauma-related neurosurgical cases. Moreover, countries like India and China are seeing a rapid upscaling in surgical capabilities in tertiary and specialty hospitals, thus encouraging adoption of advanced dural repair products. In Latin America and parts of the Middle East and Africa, market growth is comparatively nascent but gaining momentum as global medtech companies expand their presence and introduce cost-effective graft solutions tailored for emerging markets. This geographic diversification is broadening the overall market potential and ensuring a more widespread acceptance of dural graft technologies.

What Is Fueling the Growth Trajectory of the Dural Graft Market?

The growth in the dural graft market is driven by several factors. Foremost is the rising global volume of neurosurgical and spinal surgeries, necessitating effective dural repair solutions. Innovations in graft material design-such as enhanced biocompatibility, reduced inflammatory response, and support for tissue regeneration-are increasing surgeon confidence and clinical outcomes. The shift toward minimally invasive procedures also favors advanced grafts that can be deployed quickly and reliably through smaller surgical corridors. Additionally, heightened awareness of CSF-related complications and the availability of grafts with superior sealing capabilities are reducing postoperative morbidity, further boosting adoption. Regulatory approvals for new products and expanding clinical indications for graft use are making these devices more accessible in both developed and emerging healthcare systems. The rising emphasis on patient recovery metrics, hospital readmission rates, and long-term outcomes is also pushing institutions to invest in reliable and proven graft technologies. Together, these factors are propelling the global dural graft market into a phase of sustained and accelerated growth.

SCOPE OF STUDY:

The report analyzes the Dural Graft market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft, Other Products); Material (Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material, Synthetic Bovine Collagen Matrix Material, Ligamentum Nuchae Material, Other Materials); Application (Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use, Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Acera Surgical
  • Aesculap, Inc. (B. Braun)
  • Baxter International Inc.
  • Beijing TianXinFu Medical Appliance
  • B. Braun Melsungen AG
  • Collagen Matrix, Inc.
  • Cook Medical
  • Cousin Biotech
  • Guanhao Biotech
  • Gunze Limited
  • Integra LifeSciences Corporation
  • Johnson & Johnson (DePuy Synthes)
  • LeMaitre Vascular
  • Medprine
  • Medtronic plc
  • Natus Medical Incorporated
  • Nurami Medical
  • Stryker Corporation
  • Tissuemed Ltd
  • WL Gore & Associates

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Dural Graft - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Neurosurgical Procedures and Spinal Surgeries Drives Demand for Dural Graft Products
    • Growing Geriatric Population Expands Addressable Market for Dural Repair Solutions
    • Technological Advancements in Synthetic Grafts Propel Adoption Over Autografts
    • Increase in Minimally Invasive Neurosurgeries Generates Demand for Advanced Biomaterials
    • Enhanced Biocompatibility and Reduced Infection Rates Strengthen Business Case for Next-Gen Grafts
    • Government Investment in Neurotrauma and Brain Injury Treatments Spurs Market Development
    • Shift Toward Regenerative Medicine and Tissue Engineering Drives Innovation in Dural Grafts
    • Clinical Success and Outcome-Based Reimbursements Accelerate Use of Premium Products
    • Surge in Cranial and Spinal Trauma Cases Globally Generates Continuous Product Demand
    • Growing Focus on Postoperative Outcomes Throws the Spotlight on Durable and Absorbable Grafts
    • Strategic Hospital Procurement Trends Favor Multi-Functional, Long Shelf-Life Graft Options
    • Customization and Surgeon-Specific Preferences Drive Adoption of Tailored Graft Sizes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Dural Graft Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Xenogeneic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Allogenic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Synthetic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Autologous Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ligamentum Nuchae Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Bovine Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Cadaveric Dura Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Autologous Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Synthetic Bovine Collagen Matrix Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Traumatic Brain & Spine Injury Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Cerebrovascular Accident Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Cerebrospinal Fluid Accumulation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Brain & Spine Tumor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Epilepsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: World 16-Year Perspective for Trauma Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 65: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 68: USA Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: USA 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: USA 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: USA Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: USA 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Canada 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Canada 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Japan 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Japan 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 104: China Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: China 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: China 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: France 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: France 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: France 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Germany 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Germany 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Germany 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Germany 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Italy 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Italy 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Italy 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Italy 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 167: UK Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: UK 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: UK 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: UK 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: UK 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Spain 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Spain 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Spain 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Spain Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Spain Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Spain 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Russia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Russia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Russia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Russia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Russia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Russia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Australia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Australia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 236: Australia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Australia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Australia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 239: Australia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Australia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Australia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 242: India Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: India 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: India 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 248: India Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: India Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: India 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 251: India Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: India Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: India 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: South Korea 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: South Korea 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 260: South Korea Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: South Korea Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: South Korea 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 263: South Korea Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: South Korea Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: South Korea 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Rest of Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Rest of Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 287: Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 290: Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Argentina 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Argentina 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 299: Argentina Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Argentina Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Argentina 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 302: Argentina Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Argentina Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Argentina 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Brazil 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Brazil 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 311: Brazil Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Brazil Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Brazil 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 314: Brazil Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Brazil Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Brazil 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Mexico 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Mexico 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 323: Mexico Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Mexico Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Mexico 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 326: Mexico Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Mexico Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Mexico 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Rest of Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Rest of Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Rest of Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Rest of Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 350: Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 353: Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Iran 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Iran 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 362: Iran Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Iran Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Iran 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 365: Iran Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Iran Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Iran 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Israel 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Israel 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 374: Israel Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Israel Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Israel 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 377: Israel Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Israel Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Israel 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Saudi Arabia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: Saudi Arabia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Saudi Arabia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: Saudi Arabia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: UAE 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: UAE 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 398: UAE Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: UAE Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: UAE 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 401: UAE Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: UAE Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: UAE 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Rest of Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Rest of Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Rest of Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Rest of Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 418: Africa 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 421: Africa 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
    • TABLE 422: Africa Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Africa Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 424: Africa 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 425: Africa Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Africa Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 427: Africa 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제